BPC-157
BPC-157 is a synthetic peptide derived from gastric juices, extensively studied in preclinical models for its regenerative, anti-inflammatory, and angiogenic (blood vessel growth) properties. Research focuses on treating musculoskeletal injuries (tendons, ligaments, bones), inflammatory bowel disease, gastrointestinal ulcers, and accelerating wound healing.
Key Areas of BPC-157 Research:
- Musculoskeletal Regeneration: Studied for accelerating the healing of injured muscles, tendons, ligaments, and bone, specifically tendon-to-bone reconnection.
- Gastrointestinal Health: Originally investigated for its role in stomach lining protection, it is studied for treating inflammatory bowel disease (IBD) and gastric ulcers.
- Angiogenesis & Wound Healing: Research shows it promotes blood vessel formation and collagen production, leading to faster skin wound and burn repair.
- Systemic Anti-inflammatory Effects: Investigated for reducing inflammation and oxidative stress across various tissues, including potential neuroprotective effects for stroke or traumatic brain injury.
- Organ Protection: Studies indicate protective effects on the liver, pancreas, and heart.
- Drug Antagonist: Researched for its ability to counteract adverse effects of certain medications (e.g., NSAID damage) and substance toxicity.
